JPH0525045B2 - - Google Patents

Info

Publication number
JPH0525045B2
JPH0525045B2 JP17421885A JP17421885A JPH0525045B2 JP H0525045 B2 JPH0525045 B2 JP H0525045B2 JP 17421885 A JP17421885 A JP 17421885A JP 17421885 A JP17421885 A JP 17421885A JP H0525045 B2 JPH0525045 B2 JP H0525045B2
Authority
JP
Japan
Prior art keywords
oscillator
thickness
frequency
receiver
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP17421885A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6235216A (ja
Inventor
Noritoshi Nakabachi
Hiroaki Niitsuma
Kunihiko Eguchi
Ryoji Sugimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON PABURITSUKU ENJINIARINGU KK
Original Assignee
NIPPON PABURITSUKU ENJINIARINGU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON PABURITSUKU ENJINIARINGU KK filed Critical NIPPON PABURITSUKU ENJINIARINGU KK
Priority to JP17421885A priority Critical patent/JPS6235216A/ja
Publication of JPS6235216A publication Critical patent/JPS6235216A/ja
Publication of JPH0525045B2 publication Critical patent/JPH0525045B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Length Measuring Devices Characterised By Use Of Acoustic Means (AREA)
JP17421885A 1985-08-09 1985-08-09 不均質物質層の層厚非破壊測定方法および装置 Granted JPS6235216A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17421885A JPS6235216A (ja) 1985-08-09 1985-08-09 不均質物質層の層厚非破壊測定方法および装置

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17421885A JPS6235216A (ja) 1985-08-09 1985-08-09 不均質物質層の層厚非破壊測定方法および装置

Publications (2)

Publication Number Publication Date
JPS6235216A JPS6235216A (ja) 1987-02-16
JPH0525045B2 true JPH0525045B2 (enEXAMPLES) 1993-04-09

Family

ID=15974789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17421885A Granted JPS6235216A (ja) 1985-08-09 1985-08-09 不均質物質層の層厚非破壊測定方法および装置

Country Status (1)

Country Link
JP (1) JPS6235216A (enEXAMPLES)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006108643A2 (en) 2005-04-14 2006-10-19 Novartis Ag Organic compounds
WO2007121920A2 (en) 2006-04-21 2007-11-01 Novartis Ag Purine derivatives for use as adenosin a2a receptor agonists
WO2008052734A1 (en) 2006-10-30 2008-05-08 Novartis Ag Heterocyclic compounds as antiinflammatory agents
WO2008097673A1 (en) 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2009087224A1 (en) 2008-01-11 2009-07-16 Novartis Ag Pyrimidines as kinase inhibitors
WO2009150137A2 (en) 2008-06-10 2009-12-17 Novartis Ag Organic compounds
EP2206499A1 (en) 2004-11-02 2010-07-14 Novartis AG Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
EP2279777A2 (en) 2007-01-10 2011-02-02 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2286813A2 (en) 2006-01-31 2011-02-23 Novartis AG Use of naphthyridine derivatives as medicaments
EP2292619A1 (en) 2004-10-22 2011-03-09 Novartis AG Purine derivatives for use as adenonsin A-2A receptor agonists
EP2305659A1 (en) 2004-11-29 2011-04-06 Novartis AG 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
WO2011050325A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
WO2011051671A1 (en) 2009-10-28 2011-05-05 Vantia Limited Aminopyridine derivatives as kallikrein inhibitors
WO2011051672A1 (en) 2009-10-28 2011-05-05 Vantia Limited Azaindole derivatives
WO2011051673A1 (en) 2009-10-28 2011-05-05 Vantia Limited Aminothiazole derivatives useful as klk1 inhibitors
EP2332933A1 (en) 2007-05-07 2011-06-15 Novartis AG Epithelial sodium channel (ENaC) inhibitors
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
WO2011098801A1 (en) 2010-02-10 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Inflammatory disease treatment
WO2011098799A2 (en) 2010-02-10 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2011113894A1 (en) 2010-03-19 2011-09-22 Novartis Ag Pyridine and pyrazine derivative for the treatment of cf
WO2012034091A1 (en) 2010-09-09 2012-03-15 Irm Llc Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
WO2012035158A1 (en) 2010-09-17 2012-03-22 Novartis Ag Pyrazine derivatives as enac blockers
EP2444120A1 (en) 2007-12-10 2012-04-25 Novartis AG Spirocyclic amiloride analogues as ENac blockers
WO2012116217A1 (en) 2011-02-25 2012-08-30 Irm Llc Compounds and compositions as trk inhibitors
EP2532679A1 (en) 2005-10-21 2012-12-12 Novartis AG Human antibodies against il13 and therapeutic uses
WO2013030802A1 (en) 2011-09-01 2013-03-07 Novartis Ag Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038386A1 (en) 2011-09-16 2013-03-21 Novartis Ag Heterocyclic compounds for the treatment of cystic fibrosis
WO2013038390A1 (en) 2011-09-16 2013-03-21 Novartis Ag N-substituted heterocyclyl carboxamides
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013140319A1 (en) 2012-03-19 2013-09-26 Novartis Ag Crystalline form of a succinate salt
WO2014132220A1 (en) 2013-03-01 2014-09-04 Novartis Ag Solid forms of bicyclic heterocyclic derivatives as pdgf receptor mediators
EP3603634A1 (en) 2004-05-18 2020-02-05 Novartis AG Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
WO2020250116A1 (en) 2019-06-10 2020-12-17 Novartis Ag Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
WO2021038426A1 (en) 2019-08-28 2021-03-04 Novartis Ag Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832331A (ja) * 1981-08-20 1983-02-25 Toshiba Corp カラ−受像管螢光面の形成方法
JP2581929B2 (ja) * 1987-09-07 1997-02-19 株式会社 東横エルメス コンクリ−トの厚さ及び内在ひび割れ深度の測定装置
JP2006105680A (ja) * 2004-10-01 2006-04-20 Sankyo Eng Kk コンクリート構造物の非破壊検査方法
JP2012013522A (ja) * 2010-06-30 2012-01-19 Korea Atomic Energy Research Inst 超音波を用いる低周波数振動加振方法および装置
CN104964659B (zh) * 2015-05-25 2017-06-30 重庆大学 耐高温型凝固坯壳厚度电磁超声扫频检测方法及装置

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3603634A1 (en) 2004-05-18 2020-02-05 Novartis AG Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
EP2292619A1 (en) 2004-10-22 2011-03-09 Novartis AG Purine derivatives for use as adenonsin A-2A receptor agonists
EP2206499A1 (en) 2004-11-02 2010-07-14 Novartis AG Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
EP2305659A1 (en) 2004-11-29 2011-04-06 Novartis AG 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
WO2006108643A2 (en) 2005-04-14 2006-10-19 Novartis Ag Organic compounds
EP2532679A1 (en) 2005-10-21 2012-12-12 Novartis AG Human antibodies against il13 and therapeutic uses
EP2286813A2 (en) 2006-01-31 2011-02-23 Novartis AG Use of naphthyridine derivatives as medicaments
EP2322525A1 (en) 2006-04-21 2011-05-18 Novartis AG Purine derivatives for use as adenosin A2A receptor agonists
WO2007121920A2 (en) 2006-04-21 2007-11-01 Novartis Ag Purine derivatives for use as adenosin a2a receptor agonists
WO2008052734A1 (en) 2006-10-30 2008-05-08 Novartis Ag Heterocyclic compounds as antiinflammatory agents
EP2279777A2 (en) 2007-01-10 2011-02-02 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2008097673A1 (en) 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
EP2332933A1 (en) 2007-05-07 2011-06-15 Novartis AG Epithelial sodium channel (ENaC) inhibitors
EP2520574A1 (en) 2007-12-10 2012-11-07 Novartis AG Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases
EP2444120A1 (en) 2007-12-10 2012-04-25 Novartis AG Spirocyclic amiloride analogues as ENac blockers
WO2009087224A1 (en) 2008-01-11 2009-07-16 Novartis Ag Pyrimidines as kinase inhibitors
WO2009150137A2 (en) 2008-06-10 2009-12-17 Novartis Ag Organic compounds
WO2011050325A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
EP2813227A1 (en) 2009-10-22 2014-12-17 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
WO2011051673A1 (en) 2009-10-28 2011-05-05 Vantia Limited Aminothiazole derivatives useful as klk1 inhibitors
WO2011051672A1 (en) 2009-10-28 2011-05-05 Vantia Limited Azaindole derivatives
WO2011051671A1 (en) 2009-10-28 2011-05-05 Vantia Limited Aminopyridine derivatives as kallikrein inhibitors
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
WO2011098799A2 (en) 2010-02-10 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2011098801A1 (en) 2010-02-10 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Inflammatory disease treatment
WO2011113894A1 (en) 2010-03-19 2011-09-22 Novartis Ag Pyridine and pyrazine derivative for the treatment of cf
US11911371B2 (en) 2010-03-19 2024-02-27 Novartis Ag Pyridine and pyrazine derivative for the treatment of chronic bronchitis
US10117858B2 (en) 2010-03-19 2018-11-06 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
USRE46757E1 (en) 2010-03-19 2018-03-20 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
US9365552B2 (en) 2010-03-19 2016-06-14 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
EP2845593A1 (en) 2010-03-19 2015-03-11 Novartis AG Pyridine and pyrazine derivative for the treatment of chronic obstructive pulmonary disease
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
WO2012034091A1 (en) 2010-09-09 2012-03-15 Irm Llc Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
WO2012035158A1 (en) 2010-09-17 2012-03-22 Novartis Ag Pyrazine derivatives as enac blockers
WO2012116217A1 (en) 2011-02-25 2012-08-30 Irm Llc Compounds and compositions as trk inhibitors
WO2013030802A1 (en) 2011-09-01 2013-03-07 Novartis Ag Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038390A1 (en) 2011-09-16 2013-03-21 Novartis Ag N-substituted heterocyclyl carboxamides
WO2013038386A1 (en) 2011-09-16 2013-03-21 Novartis Ag Heterocyclic compounds for the treatment of cystic fibrosis
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013140319A1 (en) 2012-03-19 2013-09-26 Novartis Ag Crystalline form of a succinate salt
WO2014132220A1 (en) 2013-03-01 2014-09-04 Novartis Ag Solid forms of bicyclic heterocyclic derivatives as pdgf receptor mediators
WO2020250116A1 (en) 2019-06-10 2020-12-17 Novartis Ag Pyridine and pyrazine derivative for the treatment of cf, copd, and bronchiectasis
WO2021038426A1 (en) 2019-08-28 2021-03-04 Novartis Ag Substituted 1,3-phenyl heteroaryl derivatives and their use in the treatment of disease

Also Published As

Publication number Publication date
JPS6235216A (ja) 1987-02-16

Similar Documents

Publication Publication Date Title
JPH0525045B2 (enEXAMPLES)
Royer et al. Optical detection of sub-angstrom transient mechanical displacements
Firestone et al. Refinements in supersonic reflectoscopy. Polarized sound
US3616682A (en) Ultrasonic nondestructive thickness gauge
US4614115A (en) Ultrasonic process and apparatus for monitoring and measuring the evolution with time of physico-chemical, biological or bacteriological phenomena
US2439131A (en) Resonance inspection method
JPS6156450B2 (enEXAMPLES)
McNab et al. Monolithic phased array for the transmission of ultrasound in NDT ultrasonics
Si-Chaib et al. Applications of ultrasonic reflection mode conversion transducers in NDE
JPS63247608A (ja) コンクリ−トの厚さ及び内在ひび割れ位置の測定方法
Johnson et al. Continuous wave phase detection for probing nonlinear elastic wave interactions in rocks
SU1019312A1 (ru) Способ ультразвукового контрол клеевых изделий из диэлектрических материалов
Theobald et al. Acoustic emission transducers—development of a facility for traceable out-of-plane displacement calibration
Holbrook A pulse method for measuring small changes in ultrasonic velocity in solids with temperature
Fromme et al. Remote Monitoring of Plate‐Like Structures Using Guided Wave Arrays
Sun Application of guided acoustic waves to delamination detection
Chang et al. Experimental measurements of the phase and group velocities of body waves in a transversely isotropic medium
JPS60174949A (ja) 共鳴波空隙検知装置
SU1228007A1 (ru) Способ ультразвукового контрол изделий
KR101558922B1 (ko) 빔크기 조절이 가능한 분할형 초음파 센서
JP2861295B2 (ja) 表面波速度分布測定方法および装置
RU2034236C1 (ru) Ультразвуковой эхо-импульсный толщиномер
RU2006853C1 (ru) Ультразвуковой способ определения упругих констант твердых тел
Mailer Pavement thickness measurement using ultrasonic techniques
SU125935A1 (ru) Способ и устройство дл уменьшени мертвой зоны ультразвукового эхо дефектоскопа

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees